Correlation Between Franklin Biotechnology and Sterling Capital

Can any of the company-specific risk be diversified away by investing in both Franklin Biotechnology and Sterling Capital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Biotechnology and Sterling Capital into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Biotechnology Discovery and Sterling Capital Short, you can compare the effects of market volatilities on Franklin Biotechnology and Sterling Capital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Biotechnology with a short position of Sterling Capital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Biotechnology and Sterling Capital.

Diversification Opportunities for Franklin Biotechnology and Sterling Capital

0.01

Correlation Coefficient

Franklin Biotechnology  Sterling Capital

Significant diversification

The 3 months correlation between Franklin and STERLING is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Biotechnology Discove and Sterling Capital Short in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sterling Capital Short and Franklin Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Biotechnology Discovery are associated (or correlated) with Sterling Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sterling Capital Short has no effect on the direction of Franklin Biotechnology i.e., Franklin Biotechnology and Sterling Capital go up and down completely randomly.

Pair Corralation between Franklin Biotechnology and Sterling Capital

Assuming the 90 days horizon Franklin Biotechnology Discovery is expected to under-perform the Sterling Capital. In addition to that, Franklin Biotechnology is 10.69 times more volatile than Sterling Capital Short. It trades about -0.04 of its total potential returns per unit of risk. Sterling Capital Short is currently generating about 0.05 per unit of volatility. If you would invest  833.00  in Sterling Capital Short on September 4, 2024 and sell it today you would earn a total of  3.00  from holding Sterling Capital Short or generate 0.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Franklin Biotechnology Discove  vs.  Sterling Capital Short

Franklin Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Biotechnology Discovery has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Franklin Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sterling Capital Short

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sterling Capital Short are ranked lower than 4 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Sterling Capital is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Franklin Biotechnology and Sterling Capital

The main advantage of trading using opposite Franklin Biotechnology and Sterling Capital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Biotechnology position performs unexpectedly, Sterling Capital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sterling Capital will offset losses from the drop in Sterling Capital's long position.

The idea behind Franklin Biotechnology Discovery and Sterling Capital Short pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.